News Sentiment

ZYBT sentiment intelligence

Zhengye Biotechnology Holding Limited Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 43 Balanced news tone 36 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.75 Week of 19 Jun 2026
Weighted tone 43/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-9.7% over one week, -13.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Zhengye Biotechnology Holding Ltd (ZYBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

Market Reaction

Price moving ahead of tone

68/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -9.7% Price reacting lower
Trend fit Trend inactive -13.7% over four weeks
Fair value -80.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 15
Negative 15

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 10
Stock Titan 4
Quiver Quantitative 3
Market source 2
GlobeNewswire 2
TipRanks 2
Investing.com UK 1
Investing.com Australia 1

Event Lens

What the news is about

Classified themes
Market update 25
Earnings 6
Regulatory and legal 3
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-36 of 36
Quiver Quantitative Direct company coverage

Zhengye Biotechnology Holding Limited Highlights 2025 Achievements and 2026 Strategic Plan in Shareholder Letter

Zhengye Biotechnology Holding Limited, a veterinary vaccine manufacturer, released a shareholder letter highlighting its 2025 achievements and outlining its strategic plan for 2026. The company reported significant milestones in R&D, regulatory approvals, international market exp

Tone
Positive 75/100
Event
Regulatory and legal
Published
10 Feb 2026 13:44
Source
Quiver Quantitative
MarketBeat Direct company coverage

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Large Decline in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) experienced a significant 33.1% decrease in short interest in December, reducing the total shorted shares to 30,788. Several hedge funds, including Jane Street and Invesco, established new positions in the company despite its cu

Tone
Negative 14/100
Event
Market update
Published
29 Dec 2025 17:08
Source
MarketBeat